About
Ben Perry spent two decades in drug discovery at DNDi, Addex and UCB, co-founded AiDD SA and MPC Therapeutics SA, and maintains active publications and deep medicinal chemistry expertise.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Investments
Investor
Cosmyc TherapeuticsMy-T BioPetalion Therapeutics
Per the firm's website.